论文部分内容阅读
目的探讨米非司酮治疗妇产科疾病的临床应用效果。方法 64例妇产科住院患者,依据治疗方法不同将患者分为研究组与对照组,每组32例。研究组采用米非司酮治疗,对照组行乙烯雌酚+安宫黄体酮治疗,治疗后观察并对比两组临床效果。结果研究组患者治疗总有效率为93.8%,明显高于对照组患者的75.0%,差异具有统计学意义(P<0.05)。1年随访后,研究组患者中4例复发,复发率为12.5%(4/32);对照组患者中11例复发,复发率为34.4%(11/32);研究组患者复发率明显低于对照组(P<0.05)。结论妇产科疾病采用米非司酮治疗,可有效缓解或改善患者实际病情,降低其病情复发率,提高治疗效果,可用于临床推广与广泛应用。
Objective To investigate the clinical efficacy of mifepristone in the treatment of obstetrics and gynecology diseases. Methods 64 cases of obstetrics and gynecology inpatients, according to the different treatment methods were divided into study group and control group, 32 cases in each group. The study group was treated with mifepristone, and the control group was treated with diethylstilbestrol and medroxyprogesterone acetate. After treatment, the clinical effects were observed and compared between the two groups. Results The total effective rate of study group was 93.8%, which was significantly higher than that of the control group (75.0%), the difference was statistically significant (P <0.05). After one-year follow-up, 4 patients recurred in the study group, with a recurrence rate of 12.5% (4/32). In the control group, 11 patients relapsed and the recurrence rate was 34.4% (11/32). The recurrence rate was significantly lower in the study group In the control group (P <0.05). Conclusion Obstetrics and gynecology diseases with mifepristone treatment can effectively alleviate or improve the actual condition of patients, reduce the recurrence rate and improve the therapeutic effect, which can be used for clinical promotion and extensive application.